𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of MDR1 and MDR3 P-glycoproteins, MRP1, and BCRP/MXR/ABCP on the transport of 99mTc-tetrofosmin

✍ Scribed by Wendy S. Chen; Kathryn E. Luker; Julie L. Dahlheimer; Christina M. Pica; Gary D. Luker; David Piwnica-Worms

Book ID
113992325
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
416 KB
Volume
60
Category
Article
ISSN
0006-2952

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Impact of BCRP/MXR, MRP1 and MDR1/P-Glyc
Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells
✍ Ulrike Stein; Hermann Lage; Andreas Jordan; Wolfgang Walther; Susan E. Bates; Th πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 234 KB

## Abstract The impact of the ABC transporters breast cancer resistance protein/mitoxantrone resistance associated transporter (BCRP/MXR), multidrug resistance‐associated protein 1 (MRP1) and multidrug resistance gene‐1/P‐glycoprotein (__MDR1__/PGP) on the multidrug resistance (MDR) phenotype in ch

Individual and combined roles of CYP3A,
Individual and combined roles of CYP3A, P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) in the pharmacokinetics of docetaxel
✍ Robert A.B. van Waterschoot; Jurjen S. Lagas; Els Wagenaar; Hilde Rosing; Jos H. πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 181 KB

## Abstract Docetaxel is one of the most widely used anticancer drugs. A major problem with docetaxel treatment, however, is the considerable interpatient variability in docetaxel exposure. Another disadvantage of the drug is that it has a very low oral bioavailability and can, therefore, only be a